Efficacy of intermittent prophylaxis vis a vis no prophylactic interventions in febrile seizure recurrence: randomised controlled trail
DOI:
https://doi.org/10.18203/2320-6012.ijrms20194592Keywords:
Clobazam, Febrile seizure, Intermittent prophylaxis, Recurrent rateAbstract
Background: To compare efficacy of intermittent prophylaxis during subsequent febrile episodes with antipyretics alone or antipyretics with anticonvulsant (clobazam) vis a vis no prophylactic interventions except need-based antipyretic measures in preventing recurrence of febrile seizures.
Methods: This prospective randomized controlled interventional study was carried out in neurologically normal children. Study conducted over 14 months (March 2014 - May 2015), tertiary care hospital Mumbai. Inclusion criteria was, children aged from 6 month to 5 years with history of simple febrile seizure, lasting for less than 15 minutes, with Frequency less than one episode in 24 hours. Children with history of afebrile or complex febrile seizure, CNS comorbidity, family history of epilepsy, abnormal electroencephalogram, Unwillingness or non-feasibility of follow up were excluded from study. The patients were randomly grouped in A (No Prophylaxis n= 60), B (Antipyretic prophylaxis n=57) and C (Antipyretics + clobazam prophylaxis n=55). All cases were followed up telephonically every 15 days from date of first seizure as well as personal follow up at 1,3,6 months either in the hospital or at home. End point of study was taken as six months of follow-up from enrolment or lost-to-follow up. Efficacy of intervention was compared using chi-square test, Pearson chi-square test with/without Yates continuity correction and/or Fisher exact test, with p value of <0.05 as test of significance.
Results: Sixty cases in group A developed febrile episodes and 6 of them developed recurrence of febrile seizures, with a recurrence rate of 10% among total cases and 9.67% among all febrile episodes. Recurrence rate was significantly higher (10%) in cases who did not receive any prophylactic intervention (Group A) as compared to pooled recurrence rate in group B and C together 1.78% (p=0.022).
Conclusion: Regular antipyretic prophylaxis, alone or along with clobazam does not reduce the risk of recurrence in simple febrile seizures as compared to those who receive antipyretic intervention.
References
Mikati MA, Hani AJ. Seizures in childhood. Kliegman RM, Behrman RE, Stanton BF. Nelson textbook of Paediatrics. 19th Ed. Philadelphia. 2011:2013-37.
Dougherty D, Duffner PK, Baumann RJ, Berman P, Green JL, Schneider S, et al. Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatr. 2008;121(6):1281-6.
Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsi. 1994;35:S1-6.
Offringa M, Newton R, Cozijnsen MA, Nevitt SJ. Prophylactic drug management for febrile seizures in children. Cochra Databa Systema Revi. 2017(2).
Rose W, Kirubakaran C, Scott JX. Intermittent clobazam therapy in febrile seizures. Ind J Pediatr. 2005;72(1):31-3.
Khosroshahi N, Faramarzi F, Salamati P, Haghighi SM, Kamrani K. Diazepam versus clobazam for intermittent prophylaxis of febrile seizures. The Ind J Pediatr. 2011;78(1):38-40.
Sankar R. Paroxysmal disorders. In: Menkes JH, Sarnat HB, Maria BL, eds. Child neurology. 7th Ed. Philadelphia: Lippincott Williams and Wilkins;2006.919-922.
Shinnar, S. Febrile seizures, Swaiman KF, Ashwal S, Ferriero DM. Pediatric Neurology: Principles & Practi. 2006;13:1078-86.
Guptaa S. Febrile seizures: an overview and use of clobazam as intermittent therapy. Paediatri Toda. 2002;5(2):244-9.
Akman ÇI. Febrile seizures: the role of intermittent prophylaxis. J Pediatric Neurol. 2005;3(01):001-3.
Bajaj AS, Bajaj BK, Puri V, Tayal G. Intermittent clobazam in febrile seizures: an Indian experience. J Pediatric Neurol. 2005;3(1):19-23.
Gulati S, Saini D, Pandey RM, Kalra V. A randomized controlled trial to compare efficacy of oral clobazam with oral diazepam for prophylaxis of febrile seizures. Neuropedia. 2006;37:110.
Karande S. Febrile seizures: a review for family physicians. Ind J Medi Sci. 2007;61(3):161.
Manreza ML, Gherpelli JL, Machado-Haertel LR, Pedreira CC, Heise CO, Diament A. Treatment of febrile seizures with intermittent clobazam. Arquiv de Neuro-Psiquiat. 1997;55(4):757-61.
Camfield PR, Camfield CS, Shapiro SH, Cummings C. The first febrile seizure-antipyretic instruction plus either phenobarbital or placebo to prevent recurrence. J Pediatri. 1980;97(1):16-21.
Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM et al. Winter MR. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. New Engla J Medi. 1993;329(2):79-84.
Pavlidou E, Tzitiridou M, Ramantani G, Panteliadis C. Indications for intermittent diazepam prophylaxis in febrile seizures. Klinisc Padiatri. 2006;218(5):264-9.
Hirabayashi Y, Okumura A, Kondo T, Magota M, Kawabe S, Kando N et al. Efficacy of a diazepam suppository at preventing febrile seizure recurrence during a single febrile illness. Brai Develop. 2009;31(6):414-8.
Verrotti A, Latini G, di Corcia G, Giannuzzi R, Salladini C, Trotta D, et al. Intermittent oral diazepam prophylaxis in febrile convulsions: its effectiveness for febrile seizure recurrence. Europ J Paediatr Neurol. 2004;8(3):131-4.
Rosenbloom, E, Finkelstein Y, Adams-Webber T, Kozer E. Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis. Europ J Paediatr Neurol. 2013;17(6):585-8.
Uhari M, Rantala H, Vainionpää L, Kurttila R. Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatri. 1995;126(6):991-5.
